TickerFactsScreenerDevelopers

Dare Bioscience, Inc. (DARE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$58.40M2012: -$80.04M2013: -$94.30M2014: $45.33M2015: -$46.9K2016: -$710.6K2017: $13.29M2018: $6.73M2019: $440.8K2020: -$1.15M2021: $38.75M2022: $11.11M2023: -$5.05M2024: -$6.01M2025: $2.84M$2.84M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$2.84M+147.3%
2024-$6.01M-19.1%
2023-$5.05M-145.4%
2022$11.11M-71.3%
2021$38.75M+3464.9%
2020-$1.15M-361.3%
2019$440.8K-93.4%
2018$6.73M-49.4%
2017$13.29M+1970.6%
2016-$710.6K-1413.7%
2015-$46.9K-100.1%
2014$45.33M+148.1%
2013-$94.30M-17.8%
2012-$80.04M-37.1%
2011-$58.40M—